DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

Also called NCT04307836

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 140 participants (planned count) (from the registry)
Sponsor
Kalos Medical (from the registry)
Registry
  • NCT NCT04307836
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04307836. Randomized; no masking; primary purpose treatment. Start 2020-07-09 (actual); primary completion 2023-07-17 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications
Condition
Hypertension
Condition
Vascular Diseases
Condition
Cardiovascular Diseases
Intervention (Device)
Renal Denervation
Lead sponsor
Kalos Medical (class: industry)

Record details

Record id
cardio:ct-nct04307836
Content hash
c902fa081c2239ec7cd87f34440e77523b0cc37e18971c7e8a9909119e2a1c1d